Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
TH287 MTH1 Inhibitor: Enhancing Radiosensitivity in Cancer C
2026-05-30
TH287, a potent MTH1 inhibitor, empowers precision radiosensitization by exploiting cancer-specific DNA repair vulnerabilities. Recent breakthroughs in protocol optimization unlock selective cytotoxicity, minimizing collateral damage to healthy cells and advancing the frontier of targeted cancer research.
-
miR-18a/ALOXE3 Axis Regulates Ferroptosis in Glioblastoma
2026-05-29
This study reveals that miR-18a promotes glioblastoma progression by downregulating ALOXE3, compromising ferroptotic and anti-migratory activities. These findings highlight a novel regulatory axis in glioblastoma biology, offering new avenues for targeted research and therapeutic intervention.
-
TAK-242 (Resatorvid): Precision TLR4 Inhibition in Macrophag
2026-05-29
Explore how TAK-242 (Resatorvid) enables selective inhibition of TLR4 signaling, offering unique insights for researchers investigating inflammatory pathways, macrophage polarization, and tumor immunology. This in-depth article reveals advanced applications and practical assay decisions, building upon recent breakthroughs.
-
Calnexin-Dependent Rescue of CFTR Variants in Cystic Fibrosi
2026-05-28
Tedman et al. systematically mapped how the ER chaperone calnexin modulates both expression and pharmacological rescue of over 200 clinically relevant CFTR variants. Their findings clarify variant-specific dependencies influencing the efficacy of CFTR correctors, informing the design of more precise therapies for cystic fibrosis.
-
ETS1 Modulates Mitophagy in BPD via the SENP2/HSPA8/FUNDC1 A
2026-05-28
This study identifies ETS1 as a transcriptional regulator that mitigates mitochondrial damage-induced autophagy in bronchopulmonary dysplasia (BPD) by targeting the SENP2/HSPA8/FUNDC1 axis. The findings provide a mechanistic basis for developing new approaches in chaperone-mediated autophagy research, with implications for understanding and potentially managing BPD.
-
Torin2 mTOR Inhibitor: Precision Workflows for Cancer Resear
2026-05-27
Torin2 stands out as a next-generation mTOR inhibitor, enabling researchers to dissect the PI3K/Akt/mTOR signaling pathway with unmatched potency and selectivity. This guide delivers actionable protocols, real-world troubleshooting, and advanced use-case insights for leveraging Torin2 in apoptosis and cancer assays.
-
Suhuang Capsule Modulates ER Stress and NLRP3 Inflammasome i
2026-05-27
This study demonstrates that Suhuang antitussive capsule protects against pulmonary dysfunction in cough variant asthma by suppressing endoplasmic reticulum (ER) stress and inhibiting NLRP3 inflammasome activation. The findings provide mechanistic insight into ER stress modulation as a therapeutic strategy for airway inflammatory diseases.
-
Applied Cell Proliferation Analysis Using CCK8 in Cancer Res
2026-05-26
Leverage the Cell Counting Kit-8 (CCK-8) for streamlined, highly sensitive cell proliferation and cytotoxicity assays in cancer and neurobiology workflows. Discover new experimental strategies, troubleshooting insights, and protocol upgrades—rooted in the latest glioblastoma research and real-world laboratory experience.
-
Modulating Doxorubicin Toxicity: Deracoxib’s Role in Canine
2026-05-26
This study investigates how deracoxib, a selective COX-2 inhibitor, mitigates doxorubicin-induced cytotoxicity in normal canine mammary epithelial cells. The findings reveal that deracoxib significantly reduces apoptosis and nitric oxide overproduction triggered by doxorubicin, suggesting a potential strategy to preserve normal tissue during chemotherapy.
-
Radicicol: Hsp90 Inhibitor Workflows for Apoptosis & Inflamm
2026-05-25
Radicicol stands out as a potent Hsp90 inhibitor, enabling precise modulation of cell differentiation, apoptosis, and inflammatory responses in advanced research models. This article delivers actionable protocols, troubleshooting strategies, and integration tips for maximizing Radicicol’s performance in adipogenesis, oncology, and sepsis workflows.
-
Radioiodinated Balsalazide for Selective Imaging of Ulcerati
2026-05-25
This study presents the development and bioevaluation of radioiodinated balsalazide as a highly selective radiotracer for imaging ulcerative colitis (UC) in mice. The optimized labeling protocol and biodistribution analysis demonstrate strong colon targeting, offering a significant advance in preclinical UC imaging models.
-
AMPK Restricts ULK1-Driven Autophagy Under Energy Stress
2026-05-24
This study overturns the prevailing model of autophagy regulation by demonstrating that AMPK inhibits, rather than activates, ULK1 and autophagy during cellular energy stress. These findings reshape our understanding of autophagy signaling and highlight crucial implications for experimental design and interpretation in autophagy research.
-
Practical Guidance for Nigericin Sodium Salt in Ion Transpor
2026-05-23
Nigericin sodium salt is a potassium ionophore designed for rapid and selective ion transport studies, especially where cytoplasmic pH regulation, lead (Pb2+) transport specificity, or platelet aggregation modulation are central endpoints. It is best suited for short-term, controlled applications requiring precise ionic manipulation. Its use is not recommended in protocols dependent on aqueous solubility or long-term solution stability.
-
Bafilomycin A1 in Nanomedicine: Advancing V-ATPase Inhibitio
2026-05-22
Explore how Bafilomycin A1, a potent V-ATPase inhibitor, is reshaping nanomedicine and mRNA delivery research. This article uniquely bridges intracellular acidification control with next-generation nanoparticle-based therapeutics.
-
Clozapine N-oxide: Precision Chemogenetics for Neuronal Modu
2026-05-22
Clozapine N-oxide (CNO) is the gold-standard chemogenetic actuator, enabling highly selective and reversible neuronal activity modulation in vivo and in vitro. This article demystifies CNO’s workflow integration, protocol fine-tuning, and troubleshooting for advanced neuroscience research, with actionable insights inspired by cutting-edge hippocampal targeting studies.